Texas Oncology-Flower Mound

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Triple-negative breast cancer2 trials
• Childhood cancers1 trial
• Glioblastoma1 trial
• Head and neck cancer1 trial
• Hodgkin lymphoma1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 11 trial
• Phase 2/31 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Recruiting1 trial
• Suspended1 trial
• Terminated1 trial

Lead sponsor

• National Cancer Institute (NCI)2 trials
• NRG Oncology2 trials
• NSABP Foundation Inc1 trial
• Seagen Inc.1 trial
• Totus Medicines1 trial

Running trials

• Recruiting

  A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

  NCT05683418· Phase 1· Totus Medicines· Source

  Contact: Sarah Coates

• Active, not recruiting

  Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

  NCT03281954· Phase 3· NSABP Foundation Inc· Source

• Active, not recruiting

  Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  NCT02488967· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

  NCT02179086· Phase 2· NRG Oncology· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer1 recruiting
• Metastatic breast cancer1 recruiting

Closed trials

• Terminated

  Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

  NCT03646123· Phase 2· Seagen Inc.· Source

• Completed

  Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

  NCT01013649· Phase 3· National Cancer Institute (NCI)· Source